Molecular and cellular targets of anti-IgE antibodies

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 8, 2005, Pages 977-985

  Infuhr D ^a   Crameri, R ^b   Lamers, R ^c   Achatz, Gernot ^a,d  

^a UNIVERSITY OF SALZBURG   (Austria)

^b SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^c MPI for Immunobiology   (Germany)

^d Fachbereich für Molekulare Biologie   (Austria)

Author keywords

Anti IgE antibody; Apoptosis; B cell receptor; mIgE

Indexed keywords

HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; LEUKOTRIENE; PROSTAGLANDIN;

ALLERGIC DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; B LYMPHOCYTE; BASOPHIL; EFFECTOR CELL; HISTAMINE RELEASE; HOMEOSTASIS; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; MAST CELL; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW;

ANTIBODIES, ANTI-IDIOTYPIC; B-LYMPHOCYTES; CELL MEMBRANE; CLONAL ANERGY; DOWN-REGULATION; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNOGLOBULIN E;

EID: 21744460435     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2005.00832.x     Document Type: Review

References (52)

1. Ishizaka K, Ishizaka T, Hornbrook MM. Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. J Immunol 1966;97:840-853.
2. Venkitaraman AR, Williams GT, Dariavach P, Neuberger MS. The B-cell antigen receptor of the five immunoglobulin classes. Nature 1991;352: 777-781.
3. Achatz G, Nitschke L, Lamers MC. Effect of transmembrane and cytoplasmic domains of IgE on the IgE response. Science 1997;276:409-411.
4. Kaisho T, Schwenk F, Rajewsky K. The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. Science 1997;276:412-415.
5. Reth M. Antigen receptors on B lymphocytes. Annu Rev Immunol 1992;10:97-121.
6. Scharenberg AM, Kinet JP. Early events in mast cell signal transduction. Chem Immunol 1995;61:72-87.
7. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991;349:243-245.
8. Amiri P, Haak-Frendscho M, Robbins K, Mckerrow JH, Stewart T, Jardieu P. Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon gamma knockout mice. J Exp Med 1994;180: 43-51.
9. Durham SR, Walker SM, Varga EM, Jacobson MR, O'brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468-475.
10. Chang TW, Davis FM, Sun NC, Sun CR, Macglashan DW, Jr, Hamilton RG. Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases. Biotechnology (N Y) 1990;8:122-126.
11. Davis FM, Gossett LA, Chang TW. An epitope on membrane-bound but not secreted IgE: implications in isotype-specific regulation. Biotechnology (N Y) 1991;9:53-56.
12. Davis FM, Gossett LA, Pinkston KL, Liou RS, Sun LK, Kim YW, Chang NT, Chang TW, Wagner K, Bews J et al. Can anti-IgE be used to treat allergy? Springer Semin Immunopathol 1993;15:51-73.
13. Chang TW. The pharmacological basis of anti-IgE therapy. Nat Biotechnol 2000;18:157-162.
14. Heusser C, Jardieu P. Therapeutic potential of anti-IgE antibodies. Curr Opin Immunol 1997;9:805-813.
15. Hook WA, Zinsser FU, Berenstein EH, Siraganian RP. Monoclonal antibodies defining epitopes on human IgE. Mol Immunol 1991;28:631-639.
16. Kolbinger F, Saldanha J, Hardman N, Bendig MM. Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies. Protein Eng 1993;6:971-980.
17. Lichtenstein LM, Bochner BS. The role of basophils in asthma. Ann N Y Acad Sci 1991;629:48-61.
18. Macglashan DW, Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, Mckenzie-White J et al. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-1445.
19. Macglashan DW, Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, Lichtenstein LM. Serum IgE level drives basophil and mast cell IgE receptor display. Int Arch Allergy Immunol 1997;113:45-47.
20. Eray M, Tuomikoski T, Wu H, Nordstrom T, Andersson LC, Knuutila S et al. Cross-linking of surface IgG induces apoptosis in a bcl-2 expressing human follicular lymphoma line of mature B cell phenotype. Int Immunol 1994;6:1817-1827.
21. Warner GL, Scott DW. A polyclonal model for B cell tolerance. I. Fcdependent and Fc-independent induction of nonresponsiveness by pretreatment of normal splenic B cells with anti-Ig. J Immunol 1991;146:2185-2191.
22. Warner GL, Gaur A, Scott DW. A polyclonal model for B-cell tolerance. II. Linkage between signaling of B-cell egress from GO, class II upregulation and unresponsiveness. Cell Immunol 1991;138:404-412.
23. Nemazee D. Role of B cell antigen receptor in regulation of V(D)J recombination and cell survival. Immunol Res 2000;21:259-263.
24. Goodnow CC, Cyster JG, Hartley SB, Bell SE, Cooke MP, Healy JI et al. Self-tolerance checkpoints in B lymphocyte development. Adv Immunol 1995;59:279-368.
25. Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988;334:676-682.
26. Nemazee DA, Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989;337:562-566.
27. Raff MC, Owen JJ, Cooper MD, Lawton AR, III, Megson M, Gainings WE. Differences in susceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulin-induced immunoglobulin suppression in vitro. Possible implications for B-cell tolerance to self. J Exp Med 1975;142:1052-1064.
28. Nemazee D, Buerki K. Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc Natl Acad Sci USA 1989;86:8039-8043.
29. Goodnow CC. Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol 1992;10:489-518.
30. Goodnow CC. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci USA 1996;93:2264-2271.
31. Goodnow CC, Adelstein S, Basten A. The need for central and peripheral tolerance in the B cell repertoire. Science 1990;248:1373-1379.
32. Geisberger R, Crameri R, Achatz G. Models of signal transduction through the B-cell antigen receptor. Immunology 2003;110:401-410.
33. Carsetti R, Kohler G, Lamers MC. A role for immunoglobulin D: interference with tolerance induction. Eur J Immunol 1993;23:168-178.
34. Fulcher DA, Basten A. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med 1994;179:125-134.
35. Rathmell JC, Cooke MP, Ho WY, Grein J, Townsend SE, Davis MM et al. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 1995;376:181-184.
36. Rathmell JC, Thompson CB. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 2002;109(Suppl):S97-S107.
37. Chen HY, Liu FT, Hou CM, Huang JS, Sharma BB, Chang TW. Monoclonal antibodies against the C(epsilon)mX domain of human membrane-bound IgE and their potential use for targeting IgE-expressing B cells. Int Arch Allergy Immunol 2002;128:315-324.
38. White P, Smith H, Baker N, Davis W, Frew A. Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy 1998;28:266-270.
39. Leung DY, Sampson HA, Yunginger JW, Burks AW, Jr, Schneider LC, Wortel CH et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003;348:986-993.
40. Louis R. Anti-IgE: a significant breakthrough in the treatment of airway allergic diseases. Allergy 2004;59: 698-700.
41. Milgrom H, Fick RB, Jr, Su JQ, Reimann JD, Bush RK, Watrous ML et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhu-MAb-E25 Study Group. N Engl J Med 1999;341:1966-1973.
42. Busse W, Corren J, Lanier BQ, Mcalary M, Fowler-Taylor A, Cioppa GD et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108:184-190.
43. Vignola AM, Humbert M, Bousquet J, Boulet LP, Hedgecock S, Blogg M et al. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy 2004;59:709-717.
44. Kim YK, Oh SY, Oh HB, Chun SY, Cho SH, Koh YY et al. Coding single nucleotide polymorphism in the high-affinity immunoglobulin E receptor b chain (FcepsilonRI-beta) gene is associated with immunoglobulin E receptor-mediated histamine release from basophils. Clin Exp Allergy 2002;32:751-755.
45. Barnes PJ. Cytokine-directed therapies for asthma. J Allergy Clin Immunol 2001;108:S72-S76.
46. Borish LC, Nelson HS, Corren J, Bensch G, Busse WW, Whitmore JB et al. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol 2001;107: 963-970.
47. Herz U, Gerhold K, Gruber C, Braun A, Wahn U, Renz H et al. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 1998;102:867-874.
48. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999;29: 342-346.
49. Ormstad H, Groeng EC, Duffort O, Lovik M. The effect of endotoxin on the production of IgE, IgG1 and IgG2a antibodies against the cat allergen Fel d 1 in mice. Toxicology 2003;188: 309-318.
50. Kim TS, Dekruyff RH, Rupper R, Maecker HT, Levy S, Umetsu DT. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol 1997;158:4137-4144.
51. Lee YL, Fu CL, Ye YL, Chiang BL. Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation. Scand J Immunol 1999;49:229-236.
52. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996;87:319-329.